Enanta Pharmaceuticals reported $20.13M in Sales Revenues for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 13010M 848M
Acorda Therapeutics ACOR:US $ 28.86M 9.3M
Amgen AMGN:US $ 5901M 733M
Anika Therapeutics ANIK:US $ 34.29M 1.6M
Arrowhead Research ARWR:US $ 32.81M 11.51M
AstraZeneca AZN:LN 8220M 900M
Biocryst Pharmaceuticals BCRX:US $ 38.12M 34.1M
Biogen BIIB:US $ 2775M 81M
Bristol Myers Squibb BMY:US $ 11703M 630M
Clovis Oncology CLVS:US $ 38.05M 5.25M
Enanta Pharmaceuticals ENTA:US $ 20.13M 11.61M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
Halozyme Therapeutics HALO:US $ 89.02M 32.68M
Heron Therapeutics HRTX:US $ 20.02M 0.59M
Insmed INSM:US $ 40.21M 1.2M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
Johnson & Johnson JNJ:US $ 23312M 991M
Karyopharm Therapeutics KPTI:US $ 23.26M 11.84M
Ligand Pharmaceuticals LGND:US $ 84.68M 29.52M
Marinus Pharmaceuticals MRNS:US 1.81M 259K
Merk MRK:US $ 11402M 678M
Neurocrine Biosciences NBIX:US $ 236.6M 11.3M
Novartis NOVN:VX SF 12694M 336M
Novavax NVAX:US $ 447.23M 167.57M
Pfizer PFE:US $ 18977M 4395M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Sarepta Therapeutics SRPT:US $ 146.93M 1.79M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
YTE INCY:US $ 604.72M 184.79M